Pacific Growth Equities Morning Call Summary for July 3, 2001
07/03/01 07:45 AM
Source: Pacific Growth Equities
San Francisco, CA ¨C July 3, 2001 ¨C Pacific Growth Equities, a research driven investment bank specializing in
emerging growth companies, today reported the following from their morning call meeting:
Corixa Corp. (CRXA)
Price: $17.00
Strong Buy
Tom Dietz, Ph.D., Biotechnology/Biopharmaceuticals
¡°An article published in the Journal of Nuclear Medicine (J Nucl Med 2001; 42:907-915) provides safety data
regarding radiation exposure to household contacts following Bexxar treatment. The article provides data supporting
the safety of Bexxar as an outpatient therapy, concluding that radiation doses passed on to close contacts are unlikely
to reach the 5?mSV (millisieverts) level. The Nuclear Regulatory Commission (NRC), the body governing the release of
patients administered radioactive material, has established that a patient need not be hospitalized if the total effective
dose of a person exposed to a patient receiving radioactive material is expected to be ¡Ü 5 mSv. The article provides
dose data for 26 family members exposed to 22 patients treated with Bexxar. The patient family members¡¯ measured
doses ranged from 0.17 to 4.09 mSv with the average dose being 1.44 mSv, well below the threshold required for
hospitalization. Additional data supporting the safety of contacts to patients treated with Bexxar were presented at the
2000 American Society of Hematology meeting in San Francisco and the 1999 Annual Meeting of the American
Society of Nuclear Medicine. These data should lend confidence to doctors administering Bexxar on an outpatient
basis, simplifying the use of Bexxar for providers, patients and patient families. We reiterate our Strong Buy rating.¡± <snip>
About Pacific Growth Equities
Pacific Growth Equities is a research-driven investment bank specializing in emerging growth companies. The firm's
principal areas of focus are within the life sciences and technology sectors as well as identifying special growth
situations. Employee owned, Pacific Growth Equities offers a full range of investment banking and brokerage services
including public equity offerings, private equity offerings, proprietary sell-side research, and M&A and strategic
advisory services. For more information, please visit the website at pacificgrowthequities.com.
The information contained in this report is derived from sources we believe to be reliable, but we make no
representation that it is accurate or complete. Additional information is available. Any opinion in this report reflects our
judgment at this time and is subject to change without notice. Pacific Growth Equities, its employees and affiliates
may purchase, hold, or sell the securities of, or perform investment banking services for, any company included in this
report. This report is not a solicitation of an offer to buy or sell any security. Pacific Growth Equities may maintain a
market in the aforementioned securities and may have participated as an underwriting manager or co-manager for the
aforementioned companies. |
